GSK

LONDON, UK, 16-10-2015 — /EuropaWire/ — Geometry Global UK has announced the arrival of Juan José Posada as Chief Creative Officer. Juan José, formerly Geometry Global Executive Creative Director Latin America and Executive Creative Director Geometry Global Colombia, will relocate from Colombia … Read the full press release →

Novartis strengthens multiple sclerosis focus with the addition of Ofatumumab to leading MS portfolio which includes Gilenya and investigational treatments BAF312 and CJM112 Ofatumumab is a fully human monoclonal antibody for relapsing remitting multiple sclerosis (RRMS) which targets CD20 and … Read the full press release →

A year of collaborative projects involving Cambridge and a consortium of Paris-based universities proves the potential of international partnerships.  Cambridge, 15-7-2015 — /EuropaWire/ — When in May 2014 the Vice-Chancellor Professor Sir Leszek Borysiewicz, witnessed the signing of an agreement between … Read the full press release →

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced it is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc). LONDON, 24-6-2015 — /EuropaWire/ — The sale follows commitments given to the European Commission and other … Read the full press release →

Arzerra significantly improved PFS when added to fludarabine + cyclophosphamide (median 28.9 mos vs 18.8 mos) after initial treatment stopped working Patients receiving Arzerra plus existing CLL treatments also had a higher overall response rate (84% vs 68%) compared to … Read the full press release →

New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint London and Philadelphia, 6-4-2015 — /EuropaWire/ — GSK announced today it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre … Read the full press release →